CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 15 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,986 | -31.7% | 213,392 | 0.0% | 0.02% | -48.9% |
| Q2 2023 | $279,543 | -18.3% | 213,392 | -9.9% | 0.04% | -42.3% |
| Q1 2023 | $342,091 | -65.9% | 236,709 | -24.5% | 0.08% | -67.8% |
| Q4 2022 | $1,002,855 | +63.9% | 313,392 | +27.4% | 0.24% | +98.4% |
| Q3 2022 | $612,000 | -38.3% | 245,896 | -8.3% | 0.12% | -32.6% |
| Q2 2022 | $992,000 | -23.2% | 268,104 | 0.0% | 0.18% | +6.5% |
| Q1 2022 | $1,292,000 | -29.4% | 268,104 | +1.1% | 0.17% | -37.5% |
| Q4 2021 | $1,829,000 | -42.1% | 265,264 | -7.0% | 0.27% | +22.0% |
| Q3 2021 | $3,160,000 | -42.8% | 285,264 | -1.8% | 0.22% | -50.1% |
| Q2 2021 | $5,526,000 | – | 290,534 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,578,174 | $74,019,000 | 0.69% |
| CVI Holdings, LLC | 93,750 | $2,692,000 | 0.19% |
| Maven Securities LTD | 126,562 | $3,634,000 | 0.16% |
| BOOTHBAY FUND MANAGEMENT, LLC | 61,761 | $1,773,000 | 0.07% |
| MEITAV INVESTMENT HOUSE LTD | 8,311 | $239,000 | 0.01% |
| Ironwood Financial, llc | 167 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 76 | $2,000 | 0.00% |
| Renaissance Technologies | 7,023 | $202,000 | 0.00% |
| UBS Group AG | 834 | $24,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |